Oral vs Intravenous vs Topical Tranexamic Acid in Primary Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Study

Journal of Arthroplasty

Volumn 33, Issue 3, 2018, Pages 786-793

  Luo, Ze Yu ^a   Wang, Hao Yang ^a   Wang, Duan ^a   Zhou, Kai ^a   Pei, Fu Xing ^a   Zhou, Zong Ke ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

blood loss; intravenous; oral; topical; total hip arthroplasty; tranexamic acid

Indexed keywords

HEMOGLOBIN; PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL OUTCOME; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; WOUND COMPLICATION; BONE NECROSIS; COST; EXSANGUINATION; HIP OSTEOARTHRITIS; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; OPERATIVE BLOOD LOSS; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; SURGICAL WOUND; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COSTS AND COST ANALYSIS; DOUBLE-BLIND METHOD; EXSANGUINATION; FEMALE; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEONECROSIS; PROSPECTIVE STUDIES; SURGICAL WOUND; TRANEXAMIC ACID;

EID: 85032573821     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2017.09.062     Document Type: Article

References (42)

1. Pivec, R., Johnson, A.J., Mears, S.C., Mont, M.A., Hip arthroplasty. Lancet 380 (2012), 1768–1777.
2. Ke-Rong, D., Twenty-year accelerated development of artificial joints in China. Chin J Joint Surg, 2015, 691–694.
3. Bierbaum, B.E., Callaghan, J.J., Galante, J.O., Rubash, H.E., Tooms, R.E., Welch, R.B., An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999), 2–10.
4. Xie, J., Hu, Q., Huang, Q., Ma, J., Lei, Y., Pei, F., Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis. Thromb Res 153 (2017), 28–36.
5. Sridharan, K., Sivaramakrishnan, G., Tranexamic acid in total hip arthroplasty: a recursive cumulative meta-analysis of randomized controlled trials and assessment of publication bias. J Orthop 14 (2017), 323–328.
6. Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., Fuxing, P., Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98 (2016), 983–991.
7. Xie, J., Ma, J., Yue, C., Kang, P., Pei, F., Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int 26 (2016), 36–42.
8. Ponnusamy, K.E., Kim, T.J., Khanuja, H.S., Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am 96 (2014), 1836–1844.
9. Hallstrom, B., Singal, B., Cowen, M.E., Roberts, K.C., Hughes, R.E., The Michigan experience with safety and effectiveness of tranexamic acid use in hip and knee arthroplasty. J Bone Joint Surg Am 98 (2016), 1646–1655.
10. Yue, C., Kang, P., Yang, P., Xie, J., Pei, F., Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 29 (2014), 2452–2456.
11. Gomez-Barrena, E., Ortega-Andreu, M., Padilla-Eguiluz, N.G., Perez-Chrzanowska, H., Figueredo-Zalve, R., Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 96 (2014), 1937–1944.
12. Tzatzairis, T.K., Drosos, G.I., Kotsios, S.E., Ververidis, A.N., Vogiatzaki, T.D., Kazakos, K.I., Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study. J Arthroplasty 31 (2016), 2465–2470.
13. Drosos, G.I., Ververidis, A., Valkanis, C., Tripsianis, G., Stavroulakis, E., Vogiatzaki, T., et al. A randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement. J Orthop 13 (2016), 127–131.
14. Kayupov, E., Fillingham, Y.A., Okroj, K., Plummer, D.R., Moric, M., Gerlinger, T.L., et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 99 (2017), 373–378.
15. Parvizi, J., Miller, A.G., Gandhi, K., Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 93 (2011), 1075–1084.
16. Lei, Y.T., Xu, B., Xie, X.W., Xie, J.W., Huang, Q., Pei, F.X., The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial. Int Orthop, 2017 http://dx.doi.org/10.1007/s00264-017-3537-8 [Epub ahead of print].
17. Xie, J., Ma, J., Huang, Q., Yue, C., Pei, F., Comparison of enoxaparin and rivaroxaban in balance of anti-fibrinolysis and anticoagulation following primary total knee replacement: a pilot study. Med Sci Monit 23 (2017), 704–711.
18. Gross, J.B., Estimating allowable blood loss: corrected for dilution. Anesthesiology 58 (1983), 277–280.
19. Nadler, S.B., Hidalgo, J.H., Bloch, T., Prediction of blood volume in normal human adults. Surgery 51 (1962), 224–232.
20. Liu, X., Zhang, X., Chen, Y., Wang, Q., Jiang, Y., Zeng, B., Hidden blood loss after total hip arthroplasty. J Arthroplasty 26 (2011), 1100–1105.e1.
21. Huang, Z., Ma, J., Shen, B., Pei, F., Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 29 (2014), 2342–2346.
22. Wang, J., Wang, Q., Zhang, X., Wang, Q., Intra-articular application is more effective than intravenous application of tranexamic acid in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 32 (2017), 3385–3389.
23. Sun, Q., Yu, X., Wu, J., Ge, W., Cai, M., Li, S., Efficacy of a single dose and an additional dose of tranexamic acid in reduction of blood loss in total knee arthroplasty. J Arthroplasty 32 (2017), 2108–2112.
24. Sun, Q., Yu, X., Nie, X., Gong, J., Cai, M., The efficacy comparison of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time. J Arthroplasty 32 (2017), 33–36.
25. Yuan, X., Li, B., Wang, Q., Zhang, X., Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty 32 (2017), 2738–2743.
26. Lee, Q.J., Ching, W.Y., Wong, Y.C., Blood sparing efficacy of oral tranexamic acid in primary total knee arthroplasty: a randomized controlled trial. Knee Surg Relat Res 29 (2017), 57–62.
27. Cankaya, D., Dasar, U., Satilmis, A.B., Basaran, S.H., Akkaya, M., Bozkurt, M., The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. J Orthop Surg (Hong Kong), 25, 2017.
28. Fillingham, Y.A., Kayupov, E., Plummer, D.R., Moric, M., Gerlinger, T.L., Della Valle, C.J., The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?. J Arthroplasty 31:9 Suppl (2016), 26–30.
29. Alipour, M., Tabari, M., Keramati, M., Zarmehri, A.M., Makhmalbaf, H., Effectiveness of oral tranexamic acid administration on blood loss after knee arthroplasty: a randomized clinical trial. Transfus Apher Sci 49 (2013), 574–577.
30. Zohar, E., Ellis, M., Ifrach, N., Stern, A., Sapir, O., Fredman, B., The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99 (2004), 1679–1683 table of contents.
31. Lee, Q.J., Chang, W.Y., Wong, Y.C., Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplasty 32 (2017), 139–142.
32. Irwin, A., Khan, S.K., Jameson, S.S., Tate, R.C., Copeland, C., Reed, M.R., Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J 95-B (2013), 1556–1561.
33. Xie, J., Ma, J., Yao, H., Yue, C., Pei, F., Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty 31 (2016), 2458–2464.
34. Dunn, C.J., Goa, K.L., Tranexamic acid: a review of its use in surgery and other indications. Drugs 57 (1999), 1005–1032.
35. Wong, J., Abrishami, A., El Beheiry, H., Mahomed, N.N., Roderick Davey, J., Gandhi, R., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92 (2010), 2503–2513.
36. Kaku, Y., Ito, T., Kudo, K., Kido-Nakahara, M., Nakahara, T., Moroi, Y., et al. Generalized fixed drug eruption induced by tranexamic acid. Eur J Dermatol 24 (2014), 408–409.
37. Imbesi, S., Nettis, E., Minciullo, P.L., Di Leo, E., Saija, A., Vacca, A., et al. Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions. Pharm World Sci 32 (2010), 416–419.
38. Klak, M., Anakkala, N., Wang, W., Lange, S., Jonsson, I.M., Tarkowski, A., et al. Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis 42 (2010), 351–358.
39. Fink, B., Schuster, P., Schwenninger, C., Frommelt, L., Oremek, D., A standardized regimen for the treatment of acute postoperative infections and acute hematogenous infections associated with hip and knee arthroplasties. J Arthroplasty 32 (2017), 1255–1261.
40. Phan, D.L., Ani, F., Schwarzkopf, R., Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. J Arthroplasty 31 (2016), 579–582.
41. Tuttle, J.R., Ritterman, S.A., Cassidy, D.B., Anazonwu, W.A., Froehlich, J.A., Rubin, L.E., Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 29 (2014), 1512–1515.
42. Gillette, B.P., Maradit Kremers, H., Duncan, C.M., Smith, H.M., Trousdale, R.T., Pagnano, M.W., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 28:8 Suppl (2013), 137–139.